HLX-22
Gecertificeerd

HLX-22

Catalog #: HY-P991588-01
Maat: 1 mg
Droogijs Vereist

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

HLX-22 is a humanized monoclonal antibody targeting HER2. HLX-22 induces apoptosis in HER2-overexpressing breast and gastric cancer cells combined with Trastuzumab. HLX-22 has potent antitumor activity against advanced solid tumors[1].

CAS Number

2851060-90-5

Product Name Alternative

AC101

UNSPSC

12352203

Target

EGFR

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Purity

99.47

References & Citations

[1]Zhu X, et al. HLX22, an anti-HER-2 monoclonal antibody, in patients with advanced solid tumors overexpressing human epidermal growth factor receptor 2: an open-label, dose-escalation, phase 1 trial[J]. Investigational New Drugs, 2023, 41 (3) : 473-482.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991588/HLX-22-SDS-MedChemExpress.pdf

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Beschrijving

HLX-22 is a humanized monoclonal antibody targeting HER2. HLX-22 induces apoptosis in HER2-overexpressing breast and gastric cancer cells combined with Trastuzu

Specificaties

ProductnaamHLX-22
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-P991588-01